Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGA4 | P13612 | 12/20 | 0.54 |
| ▸ | ITGB1 | P05556 | 11/20 | 0.54 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7389747 | 0.91 | ITGA4 (0.48) | ITGA4ITGB1CHEK1RAB9AMAPT | |
| SCHEMBL7427341 | 0.88 | ITGA4 (0.55) | ITGA4ITGB1CHEK1RAB9A | |
| SCHEMBL7429378 | 0.88 | ITGA4 (0.59) | ITGA4ITGB1CHEK1 | |
| SCHEMBL7429626 | 0.88 | ITGB1 (0.59) | ITGA4ITGB1CHEK1 | |
| SCHEMBL7419719 | 0.88 | ITGA4 (0.55) | ITGA4ITGB1CHEK1RAB9AMAPT | |
| SCHEMBL7424689 | 0.87 | ITGB1 (0.55) | ITGA4ITGB1CHEK1RAB9AMAPT | |
| SCHEMBL7420868 | 0.87 | ITGA4 (0.61) | ITGA4ITGB1CHEK1 | |
| SCHEMBL7421315 | 0.87 | ITGB1 (0.57) | ITGA4ITGB1CHEK1 | |
| SCHEMBL7476969 | 0.86 | ITGA4 (0.60) | ITGA4ITGB1CHEK1 | |
| SCHEMBL7535880 | 0.85 | ITGA4 (0.55) | ITGA4ITGB1CHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6479519-B1 | INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE | AVENTIS PHARMA LIMITED (GB) | 2002-11-12 | — | — | US | disclosed |
| EP-1027328-A1 | SUBSTITUTED ANILIDES | Aventis Pharma Limited (GB) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999023063-A1 | SUBSTITUTED ANILIDES | AVENTIS PHARMA LIMITED (GB) | 1999-05-14 | — | — | WO | disclosed |